Bulletin - The Venus Times

The Venus Times

Sign in Subscribe

Bulletin

THE TOP HIGHLIGHTS

Venus Remedies Receives Malaysian PIC/S GMP Approval for Pre-Filled Syringe Facility

Venus Remedies Receives Malaysian PIC/S GMP Approval for Pre-Filled Syringe Facility

Venus Remedies is thrilled to announce a major achievement: our pre-filled syringe (PFS) manufacturing unit in Baddi has been awarded the prestigious PIC/S GMP certification by Malaysia’s National Pharmaceutical Regulatory Agency (NPRA). This is the first time our PFS facility has received accreditation under the Pharmaceutical Inspection Co-operation

Breaking Barriers with Epigenetics in the Fight Against AMR

Breaking Barriers with Epigenetics in the Fight Against AMR

We are delighted to share that Mr. Saransh Chaudhary, President of Global Critical Care at Venus Remedies Ltd and CEO of Venus Medicine Research Centre, has authored a compelling article published in Hindustan Times E-Paper. This insightful piece, titled "Opening Frontiers with Epigenetics in Battle Against AMR," sheds light on

Venus Remedies Leads Conversations on Breakthrough Diagnostic Technologies

Venus Remedies Leads Conversations on Breakthrough Diagnostic Technologies

In alignment with Venus Remedies’ commitment to driving innovation in healthcare, our President of Global Critical Care, Mr. Saransh Chaudhary, recently shared valuable insights with India Pharma Outlook. In this engaging interview, Mr. Chaudhary discussed the critical areas of sepsis and antimicrobial resistance (AMR), illuminating how innovations in diagnostics and

CPhI Milan 2024

Venus Remedies Shaping Healthcare at CPhI Milan 2024

Milan, Italy – 8-10 October 2024 Venus Remedies was once again thrilled to be a part of CPhI this year, a significant global event for the pharmaceutical industry held in the stunning city of Milan. This event brought together key industry leaders from across the globe, highlighting the importance of innovation,

Venus Remedies' Marketing Authorization

Accreditations & Approvals

Venus Remedies Secures Key Approvals in Multiple Markets

Pharma major Venus Remedies Limited has recently made significant progress in its global expansion by obtaining marketing approvals (MAs) for a wide range of drugs in different countries. We’re excited to share that Carboplatin and Carbol have been approved in Morocco, along with Bortezomib, Gemcitabine, Cefepime, and Oxaliplatin in

Venus Showcases Key Brands at ROSA CON 2024

Venus recently participated in the prestigious ROSA CON 2024, a zonal conference focusing on orthopedic specialties held in Bikaner. This event gathered leading orthopedic professionals and industry experts, providing a vital platform for sharing knowledge and advancing practices in the field. During the conference, Venus proudly showcased its prominent brands:

Venus Remedies Joins AMR Vivli to Combat Antimicrobial Resistance

Venus Remedies Joins AMR Vivli to Combat Antimicrobial Resistance

Venus Remedies is proud to announce its official membership in AMR Vivli, a global platform dedicated to sharing critical data on antimicrobial resistance (AMR). Supported by the Wellcome Trust, AMR Vivli provides a crucial platform for researchers, healthcare organizations, and industry leaders to collaborate in combating AMR, which has become

R3SET's Innovative Wellness Products Spotlighted in Harper's Bazaar

R3SET, our brand dedicated to enhancing daily wellness rituals through innovative and sustainable solutions, has been featured in the prestigious Harper's Bazaar magazine. The two-page article in the July 2024 edition, found on pages 78 and 79, highlights our unique approach and extensive product range that cater to a variety

Accreditations & Approvals

Venus Remedies Secures Major Tenders from UNICEF and PAHO to Enhance Global Healthcare

Venus Remedies Limited, a global leader in the pharmaceutical industry, has achieved significant milestones by securing two prestigious tenders from globally renowned organizations—UNICEF and the Pan American Health Organization (PAHO). These wins mark a pivotal moment in the company's journey towards enhancing healthcare access and outcomes worldwide. UNICEF Tender